Dr. Poorya Amini, Risklick · GlobeNewswire Inc. NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Citeline, a leader in clinical solutions for the life sciences industry, and Risklick, a Swiss-based company ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
There is a great need to develop, standardize, assess, and validate clinical protocols and standard operating procedures for vascularized composite allotransplantation transplants, with the goal of ...
Over its 19-year history, the BMT CTN has adapted in response to its successes and failures. It has engaged an increasingly broad and diverse group of stakeholders within the HCT and CIT fields. The ...
When discussing the future of clinical trials, people often focus on the promise of exciting new technologies, including artificial intelligence (AI) and predictive modeling. However, even the most ...
Healthcare providers working in integrative, functional and conventional medicine face a complex challenge: how to recommend high-quality supplements while maintaining clinical rigor and efficiency.
The following steps were used to achieve the objectives: Central Support: A central PSPO office was established with minimal required staffing for provision of support to clinicians for protocol ...
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Citeline, a leader in clinical solutions for the life sciences industry, and Risklick, a Swiss-based company specializing in AI-driven solutions for ...
(MENAFN- GlobeNewsWire - Nasdaq) Citeline's Best-in-Class Data and AI Combine with Risklick's End-to-End Digital Protocol Workflow NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Citeline, a leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results